GRAF ACQUISITION CORP. IV, as Issuer, AND The Investors listed in Schedule I, each as an Investor Securities Purchase Agreement Dated as of September 15, 2023 5.0% / 8.0% Convertible Senior Notes due 2027 and WarrantsSecurities Purchase Agreement • September 18th, 2023 • Graf Acquisition Corp. IV • Biological products, (no disgnostic substances) • New York
Securities Purchase Agreement, dated as of September 15, 2023 (the “Signing Date”) among Graf Acquisition Corp. IV, a Delaware corporation, as Issuer (the “Company”), and the Investors listed in Schedule I (each, an “Investor” and, collectively, the “Investors”).
